glp 1 forums April Functional Forum: GLP-1 Agonists Ozempic, Mounjaro & Co.: Erstes

$299/month, billed as $897 for 12-weeks recurring

Dosing and risk reduction Some researchers believe that slower dose escalation and lower maintenance doses may reduce the risk of severe GI complications

A doctor who studies the links between GLP-1 drugs and eye injuries says general practitioners should closely monitor eye health of people who start taking Zepbound

In 2021, AMG133, a bispecific molecule that combines GIP receptor antagonism and GLP-1 receptor agonism was presented

Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial

Conclusions and Relevance: Patent and regulatory reform is needed to ensure timely generic entry of GLP-1 receptor agonists